Erythromycin-felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice

被引:90
作者
Bailey, DG [1 ]
Bend, JR [1 ]
Arnold, JMO [1 ]
Tran, LT [1 ]
Spence, JD [1 ]
机构
[1] UNIV WESTERN ONTARIO, DEPT PHARMACOL & TOXICOL, LONDON, ON N6A 3K7, CANADA
关键词
D O I
10.1016/S0009-9236(96)90163-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To investigate a potentially marked effect by erythromycin on felodipine pharmacokinetics, to characterize the mechanism, and to compare the interaction with that between grapefruit juice and felodipine, Methods: Felodipine, 10 mg extended release, was administered with 250 mi water, 250 mg erythromycin, or 250 mi grapefruit juice in a randomized crossover study of 12 healthy men. Erythromycin base, 250 mg four times a day, was started the day before and continued on that study day, Pharmacokinetic values of felodipine, the primary metabolite dehydrofelodipine, and the major secondary derivative M3 metabolite were studied. Results: Compared with water, erythromycin produced severalfold higher felodipine area under the plasma drug concentration-time profile (AUG), plasma peak drug concentrations (C-max), and apparent elimination half-life (t(1/2)); however, the effect was variable among individuals. Erythromycin augmented dehydrofelodipine AUC, C-max, and t(1/2) but decreased dehydrofelodipine/felodipine ratios. The AUC of the M3 metabolite and the M3 metabolite/dehydrofelodipine ratios were reduced, These findings support inhibition of both metabolic pathways likely mediated by CPP3A4. Grapefruit juice produced similar mean effects but did not prolong felodipine or dehydrofelodipine t(1/2). Individually, felodipine AUC with erythromycin was greater than or similar to that with grapefruit juice. Relative felodipine AUC (erythromycin compared with grapefruit juice) correlated with relative felodipine C-max but not with relative felodipine t(1/2), suggesting felodipine AUC differed between these treatments, mainly from factors affecting presystemic drug elimination. Conclusions: Erythromycin produced an important pharmacokinetic interaction with felodipine by inhibition of drug metabolism, Although erythromycin and grapefruit juice shared a common mechanism, erythromycin likely reduced felodipine biotransformation at the gut wall and liver, whereas single-dose grapefruit juice had an effect mainly at the gut wall.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 29 条
  • [11] GUENGERICH FP, 1994, TOXICOL LETT, V70, P133
  • [12] OXIDATION OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS AND ANALOGS BY HUMAN LIVER CYTOCHROME-P-450 IIIA4
    GUENGERICH, FP
    BRIAN, WR
    IWASAKI, M
    SARI, MA
    BAARNHIELM, C
    BERNTSSON, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) : 1838 - 1844
  • [13] CHARACTERIZATION OF HUMAN CYTOCHROME-P450 ENZYMES
    GUENGERICH, FP
    [J]. FASEB JOURNAL, 1992, 6 (02) : 745 - 748
  • [14] CHANGES IN THE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC PHARMACODYNAMICS OF TERFENADINE WITH CONCOMITANT ADMINISTRATION OF ERYTHROMYCIN
    HONIG, PK
    WOOSLEY, RL
    ZAMANI, K
    CONNER, DP
    CANTILENA, LR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (03) : 231 - 238
  • [15] PLASMA-CONCENTRATIONS OF TRIAZOLAM ARE INCREASED BY CONCOMITANT INGESTION OF GRAPEFRUIT JUICE
    HUKKINEN, SK
    VARHE, A
    OLKKOLA, KT
    NEUVONEN, PJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (02) : 127 - 131
  • [16] 1ST-PASS METABOLISM OF CYCLOSPORINE BY THE GUT
    KOLARS, JC
    AWNI, WM
    MERION, RM
    WATKINS, PB
    [J]. LANCET, 1991, 338 (8781) : 1488 - 1490
  • [17] IDENTIFICATION OF RIFAMPIN-INDUCIBLE P450IIIA4 (CYP3A4) IN HUMAN SMALL-BOWEL ENTEROCYTES
    KOLARS, JC
    SCHMIEDLINREN, P
    SCHUETZ, JD
    FANG, C
    WATKINS, PB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) : 1871 - 1878
  • [18] INTERACTION BETWEEN GRAPEFRUIT JUICE AND MIDAZOLAM IN HUMANS
    KUPFERSCHMIDT, HHT
    HA, HR
    ZIEGLER, WH
    MEIER, PJ
    KRAHENBUHL, S
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) : 20 - 28
  • [19] ERYTHROMYCIN FELODIPINE INTERACTION
    LIEDHOLM, H
    NORDIN, G
    [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (09): : 1007 - 1008
  • [20] LOWN KS, 1994, DRUG METAB DISPOS, V22, P947